Inject into the lower abdominal fat at least 2 inches away from the navel, avoiding the midline
The primary concerns include enhanced gastrointestinal side effects (nausea, vomiting) due to overlapping effects on gastric emptying, potential difficulty meeting protein requirements, dehydration risk, and nutritional deficiencies
That makes it theoretically safer metabolically compared to growth hormone
References Al Amin, ASM, Gupta, V
no LD50 established even at very high doses in rodents No Hormonal Effects: Does not affect testosterone, estrogen, growth hormone, or other hormonal axes Gastric Origin: Derived from a naturally occurring human gastric protein, suggesting good biological compatibility Stability: Unusually stable in gastric acid, supporting oral administration potential Reported Effects: Anecdotal reports of fatigue, nausea in some research subjects TB-500 Safety Profile: (PMID: 20536472) Note: Published safety data is primarily available for Thymosin Beta-4
